This year’s Pharmaceutical Packaging Forum (www.packworld.com/ppf) will be held in Philadelphia on Wednesday, April 15 at the Sheraton Society Hill Hotel. For more details, call Adriene Cooper at 800-355-5595, ext. 136.
Forum attendees will learn first-hand from packaging professionals and industry experts. Presentations will offer strategies for improving package design and functionality, increasing operational efficiency, working with contract packagers/contract manufacturers, and much more. Conference attendees will have ample time to meet and network with leading solution providers and packaging colleagues from Amgen, AstraZeneca, GSK, Schering-Plough, Unisource, and other leading organizations.
Eight educational sessions will address a variety of timely topics:
• Product Ventures’ CEO Peter Clarke shares his expertise on pharmaceutical package design, compliance, and how sustainability fits into the equation.
• Zarpac’s packaging line performance expert, Paul Zepf, will explain how improved Overall Equipment Effectiveness (OEE) can increase the profitability of pharmaceutical packaging operations.
• An International Panel, sponsored by Pharmintech 2010, will feature Tassilo Korab, executive director of the European Healthcare Compliance Council, Tapan Ray, director general of the Organization of Pharmaceutical Producers of India, and a presenter from the China Pharmaceutical Assn. of Plant Engineering.
• U.S. Healthcare Packaging Compliance Council’s executive director Peter Mayberry will address packaging’s critical role and the potential impact of Walmart and other retailers prescription plans on unit-dose packaging.
• A presentation of the revised JETT Equipment Risk Assessment Model, including a presentation from Abbott Laboratories and Mel Bahr, owner of MGS Machine Corp.
• Contract packager executives Justin Schroeder of Anderson Packaging and Marc Feinberg of Sharp will head a presentation on driving packaging innovation at the contract packaging/manufacturing level, and will then take part in a question-and-answer panel.
• Dr. Michael Drues, president of Vascular Sciences, will provide the latest on advances and differences in combination products, biologics, drugs, and medical devices, insights into clinical trials, and working with the FDA.
Attendees should plan to arrive early to enjoy the opening cocktail reception on Tuesday, April 14, from 5 to 7 p.m. at the Sheraton Society Hill Hotel.
